ROSETTA CAPITAL
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments. Rosetta Capital Limited is based in London, United Kingdom.
ROSETTA CAPITAL
Status:
Active
Contact:
+44 (0) 1844 291 444
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Apache Wordpress Plugins
Similar Organizations
AIF Capital
AIF Capital Limited is a private equity and venture capital firm specializing in middle market
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-09-20 | Asarina Pharma | Rosetta Capital investment in Post-IPO Equity - Asarina Pharma | 150 M SEK |
| 2017-02-20 | Modus Therapeutics | Rosetta Capital investment in Venture Round - Modus Therapeutics | 32 M SEK |
| 2016-09-27 | Dilafor | Rosetta Capital investment in Venture Round - Dilafor | 51 M SEK |
| 2014-02-17 | NovImmune | Rosetta Capital investment in Series B - NovImmune | 66 M USD |
| 2013-03-08 | Asarina Pharma | Rosetta Capital investment in Venture Round - Asarina Pharma | N/A |
| 2013-02-13 | Biosergen AS | Rosetta Capital investment in Funding Round - Biosergen AS | N/A |
| 2013-01-01 | Aprea | Rosetta Capital investment in Series A - Aprea | N/A |
| 2010-10-11 | MerLion Pharma | Rosetta Capital investment in Series C - MerLion Pharma | 7 M USD |
| 2006-02-10 | EyeSense AG | Rosetta Capital investment in Series A - EyeSense AG | 10.7 M CHF |